IntrepidiaBio

GondolaBio

This biopharmaceutical company develops clinical-stage and preclinical medicinal therapeutics for patients living with rare genetic diseases.

Apollo Therapeutics

This biopharmaceutical company develops new medicines based on medical research for patients with various therapeutic needs.

Inspirna

This biopharmaceutical company develops novel cancer therapies for oncology patients with high unmet medical needs using a proprietary target discovery platform.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Iterion Therapeutic

This biopharmaceutical company develops small molecule inhibitors for patients with Wnt-driven cancers, including hepatocellular carcinoma and colorectal cancer.

Parabilis Medicines

This biopharmaceutical company develops helical peptide therapeutics to treat cancer and other serious diseases for patients with previously untreatable medical conditions.